メニュー
このリポジトリの skills
SkillsMP は dromlakhani/MD2SKILL から 858 件の skill を収集しています。skill を開くとソースと詳細を確認できます。
dromlakhani/MD2SKILL収集済み skill 858 件中 40 件を表示しています。
Recommends transsphenoidal surgery as the primary therapeutic option for most patients with biochemically confirmed acromegaly. Consider this recommendation when evaluating a newly diagnosed patient with elevated IGF-1 and/or clinical features suggestive of…
原文の言語: 英語
Suggests considering repeat surgery in patients with residual intrasellar disease after initial surgical resection. Consider when postoperative imaging demonstrates persistent intrasellar tumor.
原文の言語: 英語
Suggests radiation therapy for residual tumor mass after surgery when medical therapy is unavailable, unsuccessful, or not tolerated. Trigger phrases include "residual tumor mass following surgery", "medical therapy unavailable", "medical therapy…
原文の言語: 英語
The skill advises maintaining the same GH and IGF-1 assay throughout a patient's management to ensure comparable serial measurements. Trigger when ordering serial hormone tests for acromegaly monitoring, such as before and after therapy changes or during…
原文の言語: 英語
This skill suggests serial MRI imaging to assess tumor size in patients receiving pegvisomant therapy for acromegaly. Use when initiating pegvisomant or during follow‑up to monitor for tumor growth.
原文の言語: 英語
Recommends serial visual field testing during pregnancy for patients with acromegaly who harbor a macroadenoma to monitor for neurologic deterioration. Trigger when a pregnant acromegaly patient has a known pituitary macroadenoma.
原文の言語: 英語
Recommends initiating a somatostatin receptor ligand (SRL) as primary medical therapy for acromegaly when curative surgery is not possible. Consider this approach in patients with extensive cavernous sinus invasion, absence of chiasmal compression, or those…
原文の言語: 英語
Recommends stereotactic radiotherapy (SRT) over conventional radiotherapy for acromegaly when adjuvant radiation is indicated after surgery or failed medical therapy, unless SRT is unavailable, there is significant residual tumor burden, or the tumor’s…
原文の言語: 英語
This skill suggests surgical debulking for parasellar disease when total resection is unlikely due to extensive extrasellar extension seen on imaging, aiming to improve subsequent response to medical therapy. Trigger phrases include parasellar disease,…
原文の言語: 英語
Suggests a biochemical treatment goal of age-normalized serum IGF-1 value to indicate disease control in acromegaly. Use when setting therapeutic targets after initiating medical therapy or surgery, e.g., post-op IGF-1 at 12 weeks or random GH >1 µg/L.
原文の言語: 英語
Suggests using a random GH level <1.0 µg/L as a therapeutic goal to assess biochemical control of acromegaly during follow‑up after surgery or medical therapy. Use when evaluating post‑treatment response, particularly when random GH is measured alongside…
原文の言語: 英語
Suggests a trial of a dopamine agonist, usually cabergoline, as initial adjuvant therapy in patients with only modest IGF-1 elevations and mild GH excess symptoms after surgery. Use when postoperative IGF-1 is mildly elevated and symptoms of GH excess are…
原文の言語: 英語
Recommend performing abdominal ultrasound when a patient on somatostatin receptor ligand (SRL) therapy develops signs or symptoms suggestive of gallstone disease. Trigger phrases include biliary colic, postprandial right upper quadrant pain, Murphy's sign, or…
原文の言語: 英語
Recommends utilizing short-acting octreotide subcutaneous injections for disease control while awaiting conception after discontinuing long-acting somatostatin receptor ligands or pegvisomant. Trigger phrases include “preconception window,” “discontinuing…
原文の言語: 英語
Suggests performing formal visual field testing when imaging reveals tumor abutting the optic chiasm to evaluate for visual pathway compression. Trigger phrases include MRI or CT showing tumor-chiasm contact.
原文の言語: 英語
This skill determines the appropriate screening and dynamic testing procedures (e.g., insulin tolerance test, standard or high-dose ACTH stimulation) for diagnosing adrenocorticotropic hormone deficiency in childhood cancer survivors, recommending the same…
原文の言語: 英語
This skill outlines the essential patient education points for childhood cancer survivors with adrenocorticotropic hormone deficiency (ACTHD), covering stress‑dose glucocorticoid instructions, emergency injectable glucocorticoid administration, and the need…
原文の言語: 英語
This skill determines whether screening for adrenocorticotropic hormone deficiency (ACTHD) is indicated in childhood cancer survivors with hypothalamic‑pituitary axis radiation exposure between 24‑30 Gy. Screening is recommended when the survivor is >10 years…
原文の言語: 英語
This skill identifies childhood cancer survivors who require lifelong annual screening for adrenocorticotropic hormone deficiency (ACTHD) based on hypothalamic-pituitary tumor history or radiation exposure ≥30 Gy. It is triggered by clinician questions such…
原文の言語: 英語
This skill identifies the appropriate glucocorticoid replacement regimen for childhood cancer survivors with adrenocorticotropic hormone deficiency (ACTHD), recommending hydrocortisone dosing and stress coverage strategies identical to those used in the…
原文の言語: 英語
This skill determines if formal diagnostic testing for growth hormone deficiency is required in childhood cancer survivors who already have three or more confirmed anterior pituitary hormone deficiencies, as retesting may not change management. Triggers…
原文の言語: 英語
This skill determines whether to use growth hormone-releasing hormone (GHRH) alone or with arginine for diagnosing growth hormone deficiency (GHD) after hypothalamic-pituitary axis radiation exposure. It addresses clinician questions such as "Is the…
原文の言語: 英語
This skill determines whether serum insulin-like growth factor-1 (IGF-I) levels alone can be used to diagnose growth hormone deficiency (GHD) in childhood cancer survivors exposed to hypothalamic-pituitary axis radiotherapy. Triggers include questions such as…
原文の言語: 英語
This skill guides selection of an appropriate provocative test for growth hormone deficiency (GHD) diagnosis in childhood cancer survivors when clinicians ask, "What test should I use to diagnose GHD in this survivor?" or "Which provocative test is…
原文の言語: 英語
This skill identifies adult childhood cancer survivors with isolated growth hormone deficiency and prior hypothalamic‑pituitary axis radiation exposure who require retesting to confirm persistence of GHD. Triggers include clinician questions such as “Should I…
原文の言語: 英語
This skill identifies childhood cancer survivors who require lifelong periodic assessment for growth hormone deficiency based on hypothalamic-pituitary tumor history or cranial/spinal radiation exposure ≥18 Gy. It is triggered by questions such as "Does this…
原文の言語: 英語
This skill determines whether spontaneous growth hormone secretion sampling (e.g., 12-hour overnight) is appropriate for diagnosing growth hormone deficiency in childhood cancer survivors. It is triggered by clinician questions such as "Can I use overnight GH…
原文の言語: 英語
This skill determines the appropriate diagnostic strategy for luteinizing hormone/follicle-stimulating hormone deficiency (LH/FSHD) in childhood cancer survivors, recommending the use of the same diagnostic methods (e.g., GnRH stimulation test) as in the…
原文の言語: 英語
This skill identifies childhood cancer survivors who require screening for luteinizing hormone/follicle-stimulating hormone deficiency based on hypothalamic-pituitary axis radiation exposure ≥30 Gy or history of tumors/surgery affecting the HP region.…
原文の言語: 英語
This skill identifies the appropriate treatment approach for luteinizing hormone/follicle-stimulating hormone deficiency (LH/FSHD) in childhood cancer survivors. It is triggered by clinician questions such as "How should I treat LH/FSHD in this survivor?" or…
原文の言語: 英語
This skill determines the appropriate biochemical tests (e.g., free T4, TSH) for screening thyroid-stimulating hormone deficiency (TSHD) in childhood cancer survivors. It recommends using the same assays and reference ranges as in the noncancer population…
原文の言語: 英語
This skill determines whether serum triiodothyronine, thyroid-stimulating hormone surge analysis, or thyrotropin-releasing hormone stimulation should be used to diagnose thyroid-stimulating hormone deficiency in childhood cancer survivors. Triggers include:…
原文の言語: 英語
This skill identifies childhood cancer survivors who require lifelong annual screening for thyroid-stimulating hormone deficiency (TSHD) based on hypothalamic-pituitary tumor history or radiation exposure ≥30 Gy. It is triggered by clinician questions such as…
原文の言語: 英語
This skill determines the appropriate treatment approach for thyroid-stimulating hormone deficiency (TSHD) in childhood cancer survivors. It recommends using the same levothyroxine dosing and monitoring strategies (e.g., target free T4 levels) as in the…
原文の言語: 英語
Recommends daily lower-dose vitamin D over intermittent high-dose dosing for adults aged 50 years and older who have indications for vitamin D supplementation. Trigger phrases include: "Should I prescribe daily or intermittent vitamin D for this patient?" and…
原文の言語: 英語
The guideline recommends against routine 25(OH)D screening and subsequent vitamin D treatment in adults with dark complexion who lack established indications for testing. Consider this recommendation when clinicians ask, "Should I screen for vitamin D…
原文の言語: 英語
Recommends against routine 25(OH)D screening and subsequent vitamin D treatment in healthy adults without established indications. Triggered by clinician questions such as "Should I screen for vitamin D deficiency in this healthy adult?" or "Is vitamin D…
原文の言語: 英語
This skill recommends against routine 25-hydroxyvitamin D [25(OH)D] screening and subsequent vitamin D supplementation in adults with obesity when no established indication exists. It is triggered by clinician questions such as “Should I screen for vitamin D…
原文の言語: 英語
Recommends against routine vitamin D supplementation beyond the Dietary Reference Intake in adults aged 50-74 years without established indications for vitamin D treatment. Triggers include clinician questions such as "Should I prescribe vitamin D to this…
原文の言語: 英語
Recommends against empiric vitamin D supplementation beyond the Dietary Reference Intake in adults younger than 50 years. Triggered by questions such as "Should I prescribe vitamin D to this young adult?" or "Is vitamin D supplementation needed for patients…
原文の言語: 英語